Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-4-1
pubmed:abstractText
Two representative glutamate carboxypeptidase II (GCP II) inhibitors, 2-(hydroxypentafluorophenylmethyl-phosphinoylmethyl)pentanedioic acid 2 and 2-(3-mercaptopropyl)pentanedioic acid 3, were synthesized in high optical purities (>97%ee). The two enantiomers of 2 were prepared from previously reported chiral intermediates, (R)- and (S)-2-(hydroxyphosphinoylmethyl)pentanedioic acid benzyl esters 8. The synthesis of (R)- and (S)-3 involves the hydrolysis of (R)- and (S)-3-(2-oxo-tetrahydro-thiopyran-3-yl)propionic acids, (R)- and (S)-11, the corresponding optically pure thiolactones delivered by chiral chromatographic separation of the racemic 11. GCP II inhibitory assay revealed that (S)-2 is 40-fold more potent than (R)-2. In contrast, both enantiomers of 3 inhibited GCP II with nearly equal potency. The efficacy observed in subsequent animal studies with these enantiomers correlated well with the inhibitory potency in a GCP II assay.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
7
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2319-24
pubmed:meshHeading
pubmed-meshheading:15801825-Analgesics, pubmed-meshheading:15801825-Animals, pubmed-meshheading:15801825-Brain Ischemia, pubmed-meshheading:15801825-Cerebral Cortex, pubmed-meshheading:15801825-Constriction, Pathologic, pubmed-meshheading:15801825-Crystallography, X-Ray, pubmed-meshheading:15801825-Glutamate Carboxypeptidase II, pubmed-meshheading:15801825-Glutarates, pubmed-meshheading:15801825-Infarction, Middle Cerebral Artery, pubmed-meshheading:15801825-L-Lactate Dehydrogenase, pubmed-meshheading:15801825-Molecular Structure, pubmed-meshheading:15801825-Neuroprotective Agents, pubmed-meshheading:15801825-Pain, pubmed-meshheading:15801825-Peripheral Nervous System Diseases, pubmed-meshheading:15801825-Phosphinic Acids, pubmed-meshheading:15801825-Rats, pubmed-meshheading:15801825-Stereoisomerism, pubmed-meshheading:15801825-Structure-Activity Relationship, pubmed-meshheading:15801825-Sulfhydryl Compounds, pubmed-meshheading:15801825-Tissue Culture Techniques
pubmed:year
2005
pubmed:articleTitle
Enantiospecificity of glutamate carboxypeptidase II inhibition.
pubmed:affiliation
Guilford Pharmaceuticals Inc., 6611 Tributary Street, Baltimore, Maryland 21224, USA. tsukamoto@guilfordpharm.com
pubmed:publicationType
Journal Article